{
    "Symbol": "RMD",
    "AssetType": "Common Stock",
    "Name": "ResMed Inc",
    "Description": "ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.",
    "CIK": "943819",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
    "Address": "9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, US",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2023-03-31",
    "MarketCapitalization": "35399193000",
    "EBITDA": "1182173000",
    "PERatio": "43.89",
    "PEGRatio": "1.741",
    "BookValue": "22.95",
    "DividendPerShare": "0",
    "DividendYield": "0.0073",
    "EPS": "5.49",
    "RevenuePerShareTTM": "24.5",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "0.116",
    "ReturnOnEquityTTM": "23.93",
    "RevenueTTM": "3763275000",
    "GrossProfitTTM": "2063961000",
    "DilutedEPSTTM": "5.49",
    "QuarterlyEarningsGrowthYOY": "0.117",
    "QuarterlyRevenueGrowthYOY": "0.155",
    "AnalystTargetPrice": "255.78",
    "TrailingPE": "43.89",
    "ForwardPE": "35.34",
    "PriceToSalesRatioTTM": "8.69",
    "PriceToBookRatio": "9.42",
    "EVToRevenue": "9.13",
    "EVToEBITDA": "27.46",
    "Beta": "0.477",
    "52WeekHigh": "246.2",
    "52WeekLow": "188.29",
    "50DayMovingAverage": "217.5",
    "200DayMovingAverage": "221.96",
    "SharesOutstanding": "146909000",
    "DividendDate": "2023-06-15",
    "ExDividendDate": "2023-02-08"
}